CHL Hospitals 114 collaborates with Elekta

Unveils radiotherapy technology for precision cancer care

CHL Hospitals 114, Indore, in collaboration with Elekta Medical Systems India, has launched its Elekta Harmony system on World Cancer Day. It is a first-of-its-kind linear accelerator (linac) aimed at improving cancer care and providing precision radiotherapy. With this new technology, CHL Hospitals 114 expects to increase its capacity to deliver advanced, precise radiotherapy treatment to patients and improve their quality of life.


The launch took place in the presence of Mahima Chaudhary, actress and cancer survivor, along with Dr Ashwin Rangole, Director – Oncology, Sr Surgical Oncologist, Dr Piyush Shukla, HOD – Radiation Oncology, Sr Radiation Oncologist, Dhananjay Kumar, COO, CHL Hospital and Manikandan Bala, Senior VP – TIMEA and Asia Pacific, Managing Director India, Elekta.

“CHL Hospitals 114 and Elekta’s collaboration is a step closer in the direction of leveraging advanced treatment options for cancer care. Elekta Harmony is a treatment system designed to meet healthcare centres’ need for productive, precise and versatile radiotherapy treatment. It is well-equipped to address the care gap, providing a holistic ecosystem for cancer care in India,” said Dr Rangole.

 Dr Piyush Shukla, HOD – Radiation Oncology, Sr. Radiation Oncologist at the launch said, “We are happy to unveil this path-breaking therapy, a key milestone in precision radiotherapy. We at CHL are proud to bring to patients Elekta Harmony, a state-of-the-art precision radiotherapy linac. With this machine, we will ensure that patients will be provided with the same quality of therapy solutions available internationally. This technology will be accessible to more patients that need it.”

“We keep advancing our treatments and investing to improve healthcare service delivery for our patients. We are thrilled that we will now be able to offer cutting-edge technology in precision radiotherapy with Elekta Harmony for our patients in Madhya Pradesh,” said Dhananjay Kumar, COO, CHL Hospitals 114 Indore.

Manikandan Bala, Elekta’s Senior VP – TIMEA and Asia Pacific, Managing Director India, said, “Elekta Harmony marks a new chapter in advanced precision cancer treatments in India, helping to fulfil Elekta’s strategy, ACCESS 2025. With the versatility of Harmony, Elekta is in a position to make radiotherapy accessible to any centre that needs it.”

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Back to top button